Evaluation of a human bio-engineered skin equivalent for drug permeation studies

被引:65
作者
Asbill, C
Kim, N
El-Kattan, A
Creek, K
Wertz, P
Michniak, B
机构
[1] Univ S Carolina, Coll Pharm, Dept Basic Pharmaceut Sci, Columbia, SC 29208 USA
[2] Univ S Carolina, Sch Med, Dept Pediat, Childrens Canc Res Lab, Columbia, SC 29208 USA
[3] Univ S Carolina, Sch Med, Dept Pathol, Columbia, SC 29208 USA
[4] Univ Iowa, Dows Inst, Iowa City, IA 52242 USA
关键词
drug delivery systems; skin alternatives; transdermal drug delivery; permeability;
D O I
10.1023/A:1026405712870
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To test the barrier function of a bio-engineered human skin (BHS) using three model drugs (caffeine, hydrocortisone, and tamoxifen) in vitro. To investigate the lipid composition and microscopic structure of the BHS. Methods. The human skin substitute was composed of both epidermal and dermal layers, the latter having a bovine collagen matrix. The permeability of the BHS to three model drugs was compared to that obtained in other percutaneous testing models (human cadaver skin, hairless mouse skin, and EpiDerm(TM)). Lipid analysis of the BHS was performed by high performance thin layered chromatography. Histological evaluation of the BHS was performed using routine H&E staining. Results. The BHS mimicked human skin in terms of lipid composition, gross ultrastructure, and the formation of a stratum corneum. However, the permeability of the BHS to caffeine, hydrocortisone, and tamoxifen was 3-4 fold higher than that of human cadaver skin. Conclusions. In summary, the results indicate that the BHS may be an acceptable in vitro model for drug permeability testing.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 24 条
[1]   LIVING TISSUE FORMED INVITRO AND ACCEPTED AS SKIN-EQUIVALENT TISSUE OF FULL THICKNESS [J].
BELL, E ;
EHRLICH, HP ;
BUTTLE, DJ ;
NAKATSUJI, T .
SCIENCE, 1981, 211 (4486) :1052-1054
[2]   MECHANISM OF PERCUTANEOUS ABSORPTION .3. EFFECT OF TEMPERATURE ON TRANSPORT OF NON-ELECTROLYTES ACROSS SKIN [J].
BLANK, IH ;
SCHEUPLEIN, RJ ;
MACFARLANE, DJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1967, 49 (06) :582-+
[3]  
BRONAUGH RL, 1991, IN VITRO PERCUTANEOU
[4]   SKIN LIPIDS - AN UPDATE [J].
DOWNING, DT ;
STEWART, ME ;
WERTZ, PW ;
COLTON, SW ;
ABRAHAM, W ;
STRAUSS, JS .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (03) :S2-S6
[5]  
FUHRMAN LC, 1996, J CONTROL RELEASE, V45, P197
[6]   Evaluation of transdermal penetration enhancers using a novel skin alternative. [J].
Godwin, DA ;
Michniak, BB ;
Creek, KE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) :1001-1005
[7]   Percutaneous penetration enhancement activity of aromatic S,S-dimethyliminosulfuranes [J].
Kim, N ;
El-Khalili, M ;
Henary, MM ;
Strekowski, L ;
Michniak, BB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 187 (02) :219-229
[8]   BARRIER FUNCTION OF HUMAN KERATINOCYTE CULTURES GROWN AT THE AIR-LIQUID INTERFACE [J].
MAK, VHW ;
CUMPSTONE, MB ;
KENNEDY, AH ;
HARMON, CS ;
GUY, RH ;
POTTS, RO .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (03) :323-327
[9]   INVITRO EVALUATION OF A SERIES OF AZONE ANALOGS AS DERMAL PENETRATION ENHANCERS .1. [J].
MICHNIAK, BB ;
PLAYER, MR ;
CHAPMAN, JM ;
SOWELL, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 91 (01) :85-93
[10]  
MORGAN JR, 1997, SCI MED JUL, P6